RSS

GlobalData

According to data and analytics company, GlobalData, pharmaceutical sales within the age-related macular degeneration (AMD) markets will soar to $11.5 billion by the year 2026. more

Analysis

Biosimilars are increasing in popularity with pharma companies, however, an important consideration for the interested parties is knowing which markets are saturated and which are still open, according to data and analytic company, GlobalData. more

Analysis

This year will be big for Duchenne muscular dystrophy (DMD) as interest in treatments is on the rise and deal activity is increasing, reported data and analytics company, GlobalData. more

Analysis

According to data and analytics company, GlobalData, new real-world evidence will support the use of a biosimilar treatment for Crohn’s disease (CD), leading to a boost in the biosimilar market value. more

Analysis

Data and analytics company, GlobalData, has revealed 2017 was a record-breaking year for the number of approvals of biosimilars. more

Analysis

Data and analytics company, GlobalData, has observed substantial gains in market share across the seven major markets (7MM) of glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose co-transporter-2 (SGLT-2) inhibitors. more

Analysis

After the US CDC released the stats for the 2017–2018 influenza season, in which there were a reported 97 influenza-related paediatric deaths, GlobalData has reiterated its belief to move away from the chicken egg-based approach to flu vaccines more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Cases of drug-resistant epilepsy are predicted to increase by more than 100,000 by the year 2026, according to data and analytics company, GlobalData. more

Analysis

Data and analytics company, GlobalData, has released its findings from its review of the biopharmaceutical industry from 2017. more

Analysis

As a result of the outcomes of a trial comparing two drug-coated balloon (DCB) devices, in which no statistically significant patency rate difference was found, GlobalData, has indicated a potential change in the competitive landscape more

Analysis

Data and analytics company, GlobalData, has revealed its prediction that Merck will lead the way in licensing deals for the year when considering the success of the company since 2016. more

Analysis

The latest report from data and analytics company, GlobalData, has revealed that the glaucoma market is expected to grow to $3.8 billion in 2026 as a result of the launch of pipeline products. more

Analysis

Administration of quadrivalent flu jabs should be on the agenda for the NHS as fourth flu strain, known as ‘Japanese flu’ is becoming most prevalent in Europe, according to data and analytics company, GlobalData. more

Opinion

The new not-for-profit generic pharmaceutical company, to be created by five hospital organisations, is unlikely to benefit the contract manufacturing organisation (CMO) industry, according to data and analytics company, GlobalData. more

News

With festivities and holidays galore during the latter part of December we thought it would be a good idea to briefly run through some of the pharma news that came out in the run up to Christmas. more

News

The latest report from business information and analytics provider, GlobalData, has indicated that immune-oncology (IO) will become the fifth pillar of cancer treatment, joining surgery, radiotherapy, chemotherapy and other targeted treatments. more

Analysis

The research and consulting firm, GlobalData, has released a report demonstrating the expected increase in the drug delivery devices market in the Asia-Pacific (APAC) region will be larger than that of North America over the same period to 2026. more

News

Data analysis released by GlobalData has revealed that innovation in drug discovery is a driver for the pharmaceutical industry now that the age of the blockbuster appears to be at an end and research and development spending is on the up. more

News

Research and consulting firm, GlobalData, has released a report demonstrating that the Spanish pharmaceutical market is set to see a slight rise in value from $23.7 billion last year to $25.1 billion by the year 2021. more

News